SlideShare a Scribd company logo
Aaron Hogue
NIDA Grants R01DA019607, R01DA02
Family Therapy vs. Non-Family Treatment
for Adolescent Behavior Problems
in Usual Care
© CASAColumbia 2014
Aaron Hogue
Sarah Dauber
Molly Bobek
Candace Johnson
Emily Lichvar
Jon Morgenstern
Craig E. Henderson
Study Authors
© CASAColumbia 2014
Family Therapy is an
Evidence-Based Approach
(EBA) for Adolescent
Behavior Problems
What Are Adolescent
Behavior Problems?
• Conduct problems and
delinquency
• Substance misuse and
abuse
What is Family
Therapy (FT)?
• Intervene directly in
family relationships
• Address key
extrafamilial systems
(“ecological”)
Manualized FT is a
Success Story
• Win or drawn every
research comparison
with other EBAs
• There are several
brand names of
manualized FT:
• Brief Strategic Family
Therapy (BSFT), Functional
Family Therapy (FFT),
Multidimensional Family
Therapy (MDFT),
Multisystemic Therapy (MST)
© CASAColumbia 2014
What are some Barriers to
Adopting Manualized
Family Therapy?
Manualized Family
Therapy is costly
• Contract with model
purveyors
• Need for extensive
training and fidelity
monitoring procedures
• Need to renew
contracts to sustain
certification
Are EBAs superior to
usual care for youth?
• Mixed evidence when
therapists randomized
• EBAs may be less
potent for complex
cases
• Are EBAs already
prevalent in usual
care?
© CASAColumbia 2014
Is “Routine” FT
effective for ABP?
• Strong allegiance to FT in
youth services
• Not yet tested as a
generic approach in usual
care (UC)
• Can FT be a success
without the contracts and
intensive supervision by
outside experts
Evidence based
interventions
• EST = “brand-name”
manualized model
• EBP = generic, modular,
core version of EST
• EBPs are not (yet) widely
tested in routine care
What is “Routine”
Family Therapy?
© CASAColumbia 2014
Study Hypotheses
Is routine FT (RFT)
superior to Treatment
as usual (TAU) in
promoting treatment
attendance?
Will both RFT and
TAU show positive
outcomes:
• Externalizing,
Internalizing
symptoms
• Delinquency:
proportion, # acts
• Substance use:
proportion, # days
Will RFT be superior
to TAU?
© CASAColumbia 2014
Participant Recruitment
Conducted
aggressive
community outreach
• Did not use the
existing clinic referral
streams (not enough
clients)
Referral criteria
• Caregiver willing to
participate in
treatment
• Referral problems
beyond scope of
services at referral site
• Not currently in any
other behavioral
treatment
© CASAColumbia 2014
Study Eligibility Criteria:
Inclusion
Age 12-18 years
Primary caregiver
willing to participate
in treatment &
research
Health insurance
accepted by study
sites
Willingness
to engage in
treatment
MH TRACK
Met DSM-IV criteria
for oppositional
defiant disorder
(ODD) or conduct
disorder (CD)
SU TRACK
1. 1 day alcohol to
intoxication or illegal
drug use in past month
2. Endorse 1 or more DSM
symptoms of SUD
3. Met American Society of
Addiction Medicine
(ASAM) criteria for
outpatient SU treatment
© CASAColumbia 2014
Study Eligibility Criteria:
Exclusion
Mental retardation
or developmental
disorder
Current psychotic
features
Medical/
psychiatric illness
requiring
hospitalization
Suicidal
ideation
© CASAColumbia 2014
Used Intensive Linking
Procedures to Help Families
Enroll in Treatment
Intensive family
systems engagement
Counteract barriers to
enrollment
• Information
• Logistics
• Insurance
Continue through
initial intake
© CASAColumbia 2014
Screening
806
referred
433
screened
298
eligible
© CASAColumbia 2014
298
eligible
205
baselined &
randomized:
104 RFT;
101 TAU
193
completed at
least one FU:
95 RFT;
98 TAU
Enrollment & Follow Up
© CASAColumbia 2014
% of sample
Female 48%
15.4 (1.4)Age (mean/SD)
Hispanic 59%
African American 21%
Multiracial 15%
Single parent household 66%
Caregiver graduated high school 71%
Caregiver employed full or part time 64%
Household income < $15K per year 44%
History of child welfare involvement 51%
Participant Demographics
© CASAColumbia 2014
% of sample
Study Track 63% MH
37% SU
87%Oppositional Defiant Disorder
Conduct Disorder 52%
Attention Deficit Hyperactivity Disorder 74%
Mood Disorder or Dysthymia 42%
Substance Use Disorder 28%
Generalized Anxiety Disorder 17%
Posttraumatic Stress Disorder 17%
More than one disorder 78%
Track & Diagnosis
© CASAColumbia 2014
Study Sites and Therapists
RFT TAU
N Sites 1 5 clinics: Community MH,
Hospital MH, Addictions
Treatment approaches
featured
FT Diverse
N Therapists 15 17
Therapist age range 28-59 25-45
Gender Predominantly
female
Predominantly
female
Race/ethnicity Mostly Hispanic
American
Mostly European
American
Average years experience 3.1 (SD = 4.3) 3.2 (SD = 2.9)
© CASAColumbia 2014
Clinic Intake and Treatment
Attendance Rates
Full Sample RFT TAU
Total N 205 104 101
Completed intake 61% 58% 64%
Attend 1 session 39% 41% 37%
Attend >3 sessions 30% 31% 30%
Sessions attended (avg) 12.4 (10.1) 11.6 (9.9) 13.3 (10.2)
© CASAColumbia 2014
Evidence of
Implementation
Fidelity
© CASAColumbia 2014
Pre-Study Therapist Self-
Report: Proficiency in EBAs
Proficiency score:
Average skill & allegiance
Therapist rated skill
and allegiance to each
of the four EBAs:
CBT, FT, MI, DC (drug
counseling)
© CASAColumbia 2014
Differences in Therapist
Proficiency (RFT vs. TAU)
RFT TAU t p d
N therapists 10 16
FT Proficiency 3.7 (.88) 2.7 (.80) 2.8 .01 1.13
MI Proficiency 2.5 (1.0) 2.5 (1.0) -.08 .94 .03
CBT Proficiency 2.6 (.77) 3.2 (.71) -2.1 .05 .86
DC Proficiency 2.0 (.94) 2.1 (1.2) -.14 .89 .06
© CASAColumbia 2014
Therapists Self-Report of Use
of EBAs During Treatment of
Study Cases: Inventory of
Therapy Techniques (ITT)
Therapist-report:
Measure fidelity to EBAs
for ABP using 5-point
“extensiveness” scale
Item Origins:
Derived from validated
observational fidelity
scales of ESTs
27 Individual
Techniques from 4
Approaches:
CBT, FT, MI, DC
© CASAColumbia 2014
DC MI/CBT FT
RFT 1.18
(.28)
2.31
(.72)
2.68
(.70)
TAU 1.40
(.84)
2.45
(.95)
2.04
(.72)
B (SE);
pseudo-z
NS NS .53 (.19);
2.73*
TAU: CMHCs
(2 clinics)
1.03 (.09) 2.22
(.92)
1.92
(.68)
TAU: Child Psychiatry
(2 clinics)
1.19 (.17) 2.40
(.73)
1.90
(.61)
Differences Between RFT
vs. TAU in Therapist Report
of Using EBAs
© CASAColumbia 2014
Differences Between RFT
vs. TAU in Observer Report
of Using EBAs
MI/CBT FT F-test;
Effect size
RFT (n = 104) 1.6
(.40)
2.0
(.45)
p = .001;
partial η2 = .33
TAU (n = 53) 1.6
(.32)
1.4
(.36)
p = .06;
partial η2 = .07
N = 157
© CASAColumbia 2014
Apply the Template
and Your Layouts Could
Look Great
Outcome
Analyses
© CASAColumbia 2014
Study Findings:
Treatment Attendance
Client attended at
least one session
• RFT: 74%
• TAU: 79%
Average number of
sessions attended
RFT: 11.6 (SD=9.9)
TAU: 13.3 (SD=10.2)
No differences
between conditions
© CASAColumbia 2014
Analytics Procedures Used
to Test Clinical Outcomes
Latent growth
curve modeling
3-, 6-, 12-mo FU
(nested data)
Delinquency and
Substance Use
(non-normal data)
• 2-part models:
Categorical
(any vs. none)
• Continuous (if
occurred)
Externalizing and
Internalizing:
quadratic growth
functions
Covariates,
Study Track
(MH vs. SU)
© CASAColumbia 2014
Clinical Outcomes:
Externalizing Symptoms
Caregiver Report
• Overall declines in
aggression,
oppositionality,
conduct problems
• No between-condition
differences
Adolescent Report
• Overall declines in
aggression,
oppositionality,
conduct problems
• RFT produced larger
effects
© CASAColumbia 2014
Clinical Outcomes:
Internalizing Symptoms
Caregiver Report
• Overall declines in
anxiety, depression,
somatic problems
• No between-
condition differences
Adolescent Report
• Overall declines in
anxiety, depression,
somatic problems
• RFT produced larger
effects
© CASAColumbia 2014
Clinical Outcomes:
Delinquency
MH Track
• Overall declines in
delinquency:
proportion any act,
total # acts
• No between-
condition differences
SU Track
• Overall declines in
delinquency:
proportion any act,
total # acts
• RFT larger effects for
total # acts
© CASAColumbia 2014
Clinical Outcomes:
Substance Use
Full Sample
• No overall declines in
substance use
SU Track
• No overall declines in
substance use
• Significant effects for
RFT: proportion any
use, # days use
© CASAColumbia 2014
Brief Conclusions
Both RFT and TAU
promoted significant gains
in multiple problem areas
RFT Outperformed
TAU for
5 out of 12 outcomes
Effect sizes for RFT
(small to moderate)
comparable to effects
reported in meta-analyses
of efficacy studies for
manualized FTs
© CASAColumbia 2014
Study Limitations
Only 1 RFT Site
(However: No
measureable cost
or organizational
advantages for
the RFT site)
Sample NOT
referral as usual
Could not
analyze site
effects
Modest
attendance rates:
(However: Study
rates were
comparable to
routine services)
© CASAColumbia 2014
Study Implications
Routine FT can be
delivered with
fidelity and
effectiveness
in usual care
What are important
differences in
fidelity procedures
within usual care
vs. outside
contracts
FT is widely
endorsed in youth
services, but isn’t
commonly
practiced?
With fidelity?
Need more
research on
EBAs used in
routine care
© CASAColumbia 2014
This research was funded by the National Institute on Drug Abuse
(R01 DA019607 and R01 DA023945; PI: Aaron Hogue, Ph.D.; Co-I: Sarah Dauber, Ph.D.)
© CASAColumbia 2014
© CASAColumbia 2014
Related References
Hogue, A., Dauber, S., Lichvar, E., Bobek, M., & Henderson, C. E. (in press). Validity of therapist self-report
ratings of fidelity to evidence-based practices for adolescent behavior problems: Correspondence between
therapists and observers. Administration and Policy in Mental Health and Mental Health Services Research.
Hogue, A., Dauber, S., & Henderson, C. E. (2014). Therapist self-report of evidence-based practices in usual
care for adolescent behavior problems: Factor and construct validity. Administration and Policy in Mental Health
and Mental Health Services Research, 41, 126-139.
Hogue, A., & Dauber, S. (2013). Assessing fidelity to evidence-based practices in usual care: The example of
family therapy for adolescent behavior problems. Evaluation and Program Planning, 37, 21-30.
Hogue, A., & Dauber, S. (2013). Diagnostic profiles among urban adolescents with unmet treatment needs:
Comorbidity and perceived need for treatment. Journal of Emotional and Behavioral Disorders, 21, 18-32.
Dauber, S., & Hogue, A. (2011). Profiles of systems involvement in a sample of high-risk urban adolescents
with unmet treatment needs. Children and Youth Services Review, 33, 2018-2026.

More Related Content

What's hot

Comparing screening tools for intimate partner violence detection: What's the...
Comparing screening tools for intimate partner violence detection: What's the...Comparing screening tools for intimate partner violence detection: What's the...
Comparing screening tools for intimate partner violence detection: What's the...
Health Evidence™
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
OPUNITE
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
OPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
OPUNITE
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
PM Society
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
OPUNITE
 
Moving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical CareMoving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical Care
Kolmac Outpatient Recovery Centers
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
OPUNITE
 
Supporting medicines adherence developing the pharmacist contribution
Supporting medicines adherence   developing the pharmacist contributionSupporting medicines adherence   developing the pharmacist contribution
Supporting medicines adherence developing the pharmacist contribution
PM Society
 
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazRx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
OPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
OPUNITE
 
Intro to Prevention: Psychopharmacology Guest Lecture
Intro to Prevention: Psychopharmacology Guest LectureIntro to Prevention: Psychopharmacology Guest Lecture
Intro to Prevention: Psychopharmacology Guest Lecture
Julie Hynes
 
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranRevised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
OPUNITE
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Tue gs mc cance-katz
Tue gs mc cance-katzTue gs mc cance-katz
Tue gs mc cance-katz
OPUNITE
 
Improving HIV Medication Adherence Using Mobile Health Technology
Improving HIV Medication Adherence Using Mobile Health TechnologyImproving HIV Medication Adherence Using Mobile Health Technology
Improving HIV Medication Adherence Using Mobile Health Technology
Avella Specialty Pharmacy
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
OPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
OPUNITE
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
OPUNITE
 

What's hot (20)

Comparing screening tools for intimate partner violence detection: What's the...
Comparing screening tools for intimate partner violence detection: What's the...Comparing screening tools for intimate partner violence detection: What's the...
Comparing screening tools for intimate partner violence detection: What's the...
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 
Moving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical CareMoving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical Care
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Supporting medicines adherence developing the pharmacist contribution
Supporting medicines adherence   developing the pharmacist contributionSupporting medicines adherence   developing the pharmacist contribution
Supporting medicines adherence developing the pharmacist contribution
 
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazRx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Intro to Prevention: Psychopharmacology Guest Lecture
Intro to Prevention: Psychopharmacology Guest LectureIntro to Prevention: Psychopharmacology Guest Lecture
Intro to Prevention: Psychopharmacology Guest Lecture
 
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranRevised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Tue gs mc cance-katz
Tue gs mc cance-katzTue gs mc cance-katz
Tue gs mc cance-katz
 
Improving HIV Medication Adherence Using Mobile Health Technology
Improving HIV Medication Adherence Using Mobile Health TechnologyImproving HIV Medication Adherence Using Mobile Health Technology
Improving HIV Medication Adherence Using Mobile Health Technology
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
 

Viewers also liked

ADHD in Adolescence
ADHD in AdolescenceADHD in Adolescence
ADHD in Adolescence
Center on Addiction
 
Beyond Cigarettes: The Risks of Non-Cigarette Nicotine Products and Implicati...
Beyond Cigarettes: The Risks of Non-Cigarette Nicotine Products and Implicati...Beyond Cigarettes: The Risks of Non-Cigarette Nicotine Products and Implicati...
Beyond Cigarettes: The Risks of Non-Cigarette Nicotine Products and Implicati...
Center on Addiction
 
Adolescent Substance Use: America’s #1 Public Health Problem
Adolescent Substance Use: America’s #1 Public Health ProblemAdolescent Substance Use: America’s #1 Public Health Problem
Adolescent Substance Use: America’s #1 Public Health Problem
Center on Addiction
 
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Center on Addiction
 
Behind Bars II: Substance Use and America’s Prison Population
Behind Bars II: Substance Use and America’s Prison PopulationBehind Bars II: Substance Use and America’s Prison Population
Behind Bars II: Substance Use and America’s Prison Population
Center on Addiction
 
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Center on Addiction
 
Overview of Medications to Treat Addiction in Primary Care
Overview of Medications to Treat Addiction in Primary CareOverview of Medications to Treat Addiction in Primary Care
Overview of Medications to Treat Addiction in Primary Care
Center on Addiction
 
National Survey of American Attitudes on Substance Abuse XVII: Teens
National Survey of American Attitudes on Substance Abuse XVII: TeensNational Survey of American Attitudes on Substance Abuse XVII: Teens
National Survey of American Attitudes on Substance Abuse XVII: Teens
Center on Addiction
 
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Center on Addiction
 
Understanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior ChangeUnderstanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior Change
Center on Addiction
 
Addiction Medicine: Closing the Gap between Science and Practice
Addiction Medicine: Closing the Gap between Science and PracticeAddiction Medicine: Closing the Gap between Science and Practice
Addiction Medicine: Closing the Gap between Science and Practice
Center on Addiction
 
Overview of Addiction Medicine for Primary Care
Overview of Addiction Medicine for Primary CareOverview of Addiction Medicine for Primary Care
Overview of Addiction Medicine for Primary Care
Center on Addiction
 

Viewers also liked (12)

ADHD in Adolescence
ADHD in AdolescenceADHD in Adolescence
ADHD in Adolescence
 
Beyond Cigarettes: The Risks of Non-Cigarette Nicotine Products and Implicati...
Beyond Cigarettes: The Risks of Non-Cigarette Nicotine Products and Implicati...Beyond Cigarettes: The Risks of Non-Cigarette Nicotine Products and Implicati...
Beyond Cigarettes: The Risks of Non-Cigarette Nicotine Products and Implicati...
 
Adolescent Substance Use: America’s #1 Public Health Problem
Adolescent Substance Use: America’s #1 Public Health ProblemAdolescent Substance Use: America’s #1 Public Health Problem
Adolescent Substance Use: America’s #1 Public Health Problem
 
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
 
Behind Bars II: Substance Use and America’s Prison Population
Behind Bars II: Substance Use and America’s Prison PopulationBehind Bars II: Substance Use and America’s Prison Population
Behind Bars II: Substance Use and America’s Prison Population
 
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
 
Overview of Medications to Treat Addiction in Primary Care
Overview of Medications to Treat Addiction in Primary CareOverview of Medications to Treat Addiction in Primary Care
Overview of Medications to Treat Addiction in Primary Care
 
National Survey of American Attitudes on Substance Abuse XVII: Teens
National Survey of American Attitudes on Substance Abuse XVII: TeensNational Survey of American Attitudes on Substance Abuse XVII: Teens
National Survey of American Attitudes on Substance Abuse XVII: Teens
 
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
 
Understanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior ChangeUnderstanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior Change
 
Addiction Medicine: Closing the Gap between Science and Practice
Addiction Medicine: Closing the Gap between Science and PracticeAddiction Medicine: Closing the Gap between Science and Practice
Addiction Medicine: Closing the Gap between Science and Practice
 
Overview of Addiction Medicine for Primary Care
Overview of Addiction Medicine for Primary CareOverview of Addiction Medicine for Primary Care
Overview of Addiction Medicine for Primary Care
 

Similar to Does family therapy for adolescent behavior problems work in the real world

How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
Todd Berner MD
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
Todd Berner MD
 
Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)
MarksMan Healthcare Communications
 
Critical Apprasial
Critical Apprasial Critical Apprasial
Critical Apprasial
Nahid Sherbini
 
Critical apprasial 2
Critical apprasial 2Critical apprasial 2
Critical apprasial 2
Nahid Sherbini
 
Implementation science
Implementation scienceImplementation science
Implementation science
Rukman Mecca
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
OPUNITE
 
Helping Couples and Families – Suggestions for Adapting Relationship Services...
Helping Couples and Families – Suggestions for Adapting Relationship Services...Helping Couples and Families – Suggestions for Adapting Relationship Services...
Helping Couples and Families – Suggestions for Adapting Relationship Services...
FRSA Communications
 
Building an Collaborative Care Infrastructure for Opioid-Addicted Patients in...
Building an Collaborative Care Infrastructure for Opioid-Addicted Patients in...Building an Collaborative Care Infrastructure for Opioid-Addicted Patients in...
Building an Collaborative Care Infrastructure for Opioid-Addicted Patients in...
BU School of Medicine
 
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
Judith Carrier_LTC Consensus Meeting 10-Nov-2015Judith Carrier_LTC Consensus Meeting 10-Nov-2015
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
angewatkins
 
Interventions for preventing elder abuse: What's the evidence?
Interventions for preventing elder abuse: What's the evidence?Interventions for preventing elder abuse: What's the evidence?
Interventions for preventing elder abuse: What's the evidence?
Health Evidence™
 
Duration of Psychological Therapy
Duration of Psychological TherapyDuration of Psychological Therapy
Duration of Psychological Therapy
Scott Miller
 
Rx15 treat tues_200_1_baxter_2barnes_3jeter_4kirsh
Rx15 treat tues_200_1_baxter_2barnes_3jeter_4kirshRx15 treat tues_200_1_baxter_2barnes_3jeter_4kirsh
Rx15 treat tues_200_1_baxter_2barnes_3jeter_4kirsh
OPUNITE
 
RGC Telehealth, Megan Coffman - SLC 2015
RGC Telehealth, Megan Coffman - SLC 2015RGC Telehealth, Megan Coffman - SLC 2015
RGC Telehealth, Megan Coffman - SLC 2015
American Academy of Family Physicians
 
Is Internet Cognitive Behavioral Therapy an effective alternative to Cognitiv...
Is Internet Cognitive Behavioral Therapy an effective alternative to Cognitiv...Is Internet Cognitive Behavioral Therapy an effective alternative to Cognitiv...
Is Internet Cognitive Behavioral Therapy an effective alternative to Cognitiv...
Jessica Short
 
1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx
DrAllaAddinAlsyany
 
Rx15 treat wed_1230_1_gitlow_2gastfriend
Rx15 treat wed_1230_1_gitlow_2gastfriendRx15 treat wed_1230_1_gitlow_2gastfriend
Rx15 treat wed_1230_1_gitlow_2gastfriend
OPUNITE
 
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Tanisha Davis
 
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Tanisha Davis
 
TACT: a trial of interventions to improve the use of malaria rd ts hreyburn
TACT: a trial of interventions to improve the use of malaria rd ts hreyburnTACT: a trial of interventions to improve the use of malaria rd ts hreyburn
TACT: a trial of interventions to improve the use of malaria rd ts hreyburn
ACT Consortium
 

Similar to Does family therapy for adolescent behavior problems work in the real world (20)

How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
 
Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)
 
Critical Apprasial
Critical Apprasial Critical Apprasial
Critical Apprasial
 
Critical apprasial 2
Critical apprasial 2Critical apprasial 2
Critical apprasial 2
 
Implementation science
Implementation scienceImplementation science
Implementation science
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
 
Helping Couples and Families – Suggestions for Adapting Relationship Services...
Helping Couples and Families – Suggestions for Adapting Relationship Services...Helping Couples and Families – Suggestions for Adapting Relationship Services...
Helping Couples and Families – Suggestions for Adapting Relationship Services...
 
Building an Collaborative Care Infrastructure for Opioid-Addicted Patients in...
Building an Collaborative Care Infrastructure for Opioid-Addicted Patients in...Building an Collaborative Care Infrastructure for Opioid-Addicted Patients in...
Building an Collaborative Care Infrastructure for Opioid-Addicted Patients in...
 
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
Judith Carrier_LTC Consensus Meeting 10-Nov-2015Judith Carrier_LTC Consensus Meeting 10-Nov-2015
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
 
Interventions for preventing elder abuse: What's the evidence?
Interventions for preventing elder abuse: What's the evidence?Interventions for preventing elder abuse: What's the evidence?
Interventions for preventing elder abuse: What's the evidence?
 
Duration of Psychological Therapy
Duration of Psychological TherapyDuration of Psychological Therapy
Duration of Psychological Therapy
 
Rx15 treat tues_200_1_baxter_2barnes_3jeter_4kirsh
Rx15 treat tues_200_1_baxter_2barnes_3jeter_4kirshRx15 treat tues_200_1_baxter_2barnes_3jeter_4kirsh
Rx15 treat tues_200_1_baxter_2barnes_3jeter_4kirsh
 
RGC Telehealth, Megan Coffman - SLC 2015
RGC Telehealth, Megan Coffman - SLC 2015RGC Telehealth, Megan Coffman - SLC 2015
RGC Telehealth, Megan Coffman - SLC 2015
 
Is Internet Cognitive Behavioral Therapy an effective alternative to Cognitiv...
Is Internet Cognitive Behavioral Therapy an effective alternative to Cognitiv...Is Internet Cognitive Behavioral Therapy an effective alternative to Cognitiv...
Is Internet Cognitive Behavioral Therapy an effective alternative to Cognitiv...
 
1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx
 
Rx15 treat wed_1230_1_gitlow_2gastfriend
Rx15 treat wed_1230_1_gitlow_2gastfriendRx15 treat wed_1230_1_gitlow_2gastfriend
Rx15 treat wed_1230_1_gitlow_2gastfriend
 
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
 
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
 
TACT: a trial of interventions to improve the use of malaria rd ts hreyburn
TACT: a trial of interventions to improve the use of malaria rd ts hreyburnTACT: a trial of interventions to improve the use of malaria rd ts hreyburn
TACT: a trial of interventions to improve the use of malaria rd ts hreyburn
 

Recently uploaded

Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 

Recently uploaded (20)

Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 

Does family therapy for adolescent behavior problems work in the real world

  • 1. Aaron Hogue NIDA Grants R01DA019607, R01DA02 Family Therapy vs. Non-Family Treatment for Adolescent Behavior Problems in Usual Care © CASAColumbia 2014
  • 2. Aaron Hogue Sarah Dauber Molly Bobek Candace Johnson Emily Lichvar Jon Morgenstern Craig E. Henderson Study Authors © CASAColumbia 2014
  • 3. Family Therapy is an Evidence-Based Approach (EBA) for Adolescent Behavior Problems What Are Adolescent Behavior Problems? • Conduct problems and delinquency • Substance misuse and abuse What is Family Therapy (FT)? • Intervene directly in family relationships • Address key extrafamilial systems (“ecological”) Manualized FT is a Success Story • Win or drawn every research comparison with other EBAs • There are several brand names of manualized FT: • Brief Strategic Family Therapy (BSFT), Functional Family Therapy (FFT), Multidimensional Family Therapy (MDFT), Multisystemic Therapy (MST) © CASAColumbia 2014
  • 4. What are some Barriers to Adopting Manualized Family Therapy? Manualized Family Therapy is costly • Contract with model purveyors • Need for extensive training and fidelity monitoring procedures • Need to renew contracts to sustain certification Are EBAs superior to usual care for youth? • Mixed evidence when therapists randomized • EBAs may be less potent for complex cases • Are EBAs already prevalent in usual care? © CASAColumbia 2014
  • 5. Is “Routine” FT effective for ABP? • Strong allegiance to FT in youth services • Not yet tested as a generic approach in usual care (UC) • Can FT be a success without the contracts and intensive supervision by outside experts Evidence based interventions • EST = “brand-name” manualized model • EBP = generic, modular, core version of EST • EBPs are not (yet) widely tested in routine care What is “Routine” Family Therapy? © CASAColumbia 2014
  • 6. Study Hypotheses Is routine FT (RFT) superior to Treatment as usual (TAU) in promoting treatment attendance? Will both RFT and TAU show positive outcomes: • Externalizing, Internalizing symptoms • Delinquency: proportion, # acts • Substance use: proportion, # days Will RFT be superior to TAU? © CASAColumbia 2014
  • 7. Participant Recruitment Conducted aggressive community outreach • Did not use the existing clinic referral streams (not enough clients) Referral criteria • Caregiver willing to participate in treatment • Referral problems beyond scope of services at referral site • Not currently in any other behavioral treatment © CASAColumbia 2014
  • 8. Study Eligibility Criteria: Inclusion Age 12-18 years Primary caregiver willing to participate in treatment & research Health insurance accepted by study sites Willingness to engage in treatment MH TRACK Met DSM-IV criteria for oppositional defiant disorder (ODD) or conduct disorder (CD) SU TRACK 1. 1 day alcohol to intoxication or illegal drug use in past month 2. Endorse 1 or more DSM symptoms of SUD 3. Met American Society of Addiction Medicine (ASAM) criteria for outpatient SU treatment © CASAColumbia 2014
  • 9. Study Eligibility Criteria: Exclusion Mental retardation or developmental disorder Current psychotic features Medical/ psychiatric illness requiring hospitalization Suicidal ideation © CASAColumbia 2014
  • 10. Used Intensive Linking Procedures to Help Families Enroll in Treatment Intensive family systems engagement Counteract barriers to enrollment • Information • Logistics • Insurance Continue through initial intake © CASAColumbia 2014
  • 12. 298 eligible 205 baselined & randomized: 104 RFT; 101 TAU 193 completed at least one FU: 95 RFT; 98 TAU Enrollment & Follow Up © CASAColumbia 2014
  • 13. % of sample Female 48% 15.4 (1.4)Age (mean/SD) Hispanic 59% African American 21% Multiracial 15% Single parent household 66% Caregiver graduated high school 71% Caregiver employed full or part time 64% Household income < $15K per year 44% History of child welfare involvement 51% Participant Demographics © CASAColumbia 2014
  • 14. % of sample Study Track 63% MH 37% SU 87%Oppositional Defiant Disorder Conduct Disorder 52% Attention Deficit Hyperactivity Disorder 74% Mood Disorder or Dysthymia 42% Substance Use Disorder 28% Generalized Anxiety Disorder 17% Posttraumatic Stress Disorder 17% More than one disorder 78% Track & Diagnosis © CASAColumbia 2014
  • 15. Study Sites and Therapists RFT TAU N Sites 1 5 clinics: Community MH, Hospital MH, Addictions Treatment approaches featured FT Diverse N Therapists 15 17 Therapist age range 28-59 25-45 Gender Predominantly female Predominantly female Race/ethnicity Mostly Hispanic American Mostly European American Average years experience 3.1 (SD = 4.3) 3.2 (SD = 2.9) © CASAColumbia 2014
  • 16. Clinic Intake and Treatment Attendance Rates Full Sample RFT TAU Total N 205 104 101 Completed intake 61% 58% 64% Attend 1 session 39% 41% 37% Attend >3 sessions 30% 31% 30% Sessions attended (avg) 12.4 (10.1) 11.6 (9.9) 13.3 (10.2) © CASAColumbia 2014
  • 18. Pre-Study Therapist Self- Report: Proficiency in EBAs Proficiency score: Average skill & allegiance Therapist rated skill and allegiance to each of the four EBAs: CBT, FT, MI, DC (drug counseling) © CASAColumbia 2014
  • 19. Differences in Therapist Proficiency (RFT vs. TAU) RFT TAU t p d N therapists 10 16 FT Proficiency 3.7 (.88) 2.7 (.80) 2.8 .01 1.13 MI Proficiency 2.5 (1.0) 2.5 (1.0) -.08 .94 .03 CBT Proficiency 2.6 (.77) 3.2 (.71) -2.1 .05 .86 DC Proficiency 2.0 (.94) 2.1 (1.2) -.14 .89 .06 © CASAColumbia 2014
  • 20. Therapists Self-Report of Use of EBAs During Treatment of Study Cases: Inventory of Therapy Techniques (ITT) Therapist-report: Measure fidelity to EBAs for ABP using 5-point “extensiveness” scale Item Origins: Derived from validated observational fidelity scales of ESTs 27 Individual Techniques from 4 Approaches: CBT, FT, MI, DC © CASAColumbia 2014
  • 21. DC MI/CBT FT RFT 1.18 (.28) 2.31 (.72) 2.68 (.70) TAU 1.40 (.84) 2.45 (.95) 2.04 (.72) B (SE); pseudo-z NS NS .53 (.19); 2.73* TAU: CMHCs (2 clinics) 1.03 (.09) 2.22 (.92) 1.92 (.68) TAU: Child Psychiatry (2 clinics) 1.19 (.17) 2.40 (.73) 1.90 (.61) Differences Between RFT vs. TAU in Therapist Report of Using EBAs © CASAColumbia 2014
  • 22. Differences Between RFT vs. TAU in Observer Report of Using EBAs MI/CBT FT F-test; Effect size RFT (n = 104) 1.6 (.40) 2.0 (.45) p = .001; partial η2 = .33 TAU (n = 53) 1.6 (.32) 1.4 (.36) p = .06; partial η2 = .07 N = 157 © CASAColumbia 2014
  • 23. Apply the Template and Your Layouts Could Look Great Outcome Analyses © CASAColumbia 2014
  • 24. Study Findings: Treatment Attendance Client attended at least one session • RFT: 74% • TAU: 79% Average number of sessions attended RFT: 11.6 (SD=9.9) TAU: 13.3 (SD=10.2) No differences between conditions © CASAColumbia 2014
  • 25. Analytics Procedures Used to Test Clinical Outcomes Latent growth curve modeling 3-, 6-, 12-mo FU (nested data) Delinquency and Substance Use (non-normal data) • 2-part models: Categorical (any vs. none) • Continuous (if occurred) Externalizing and Internalizing: quadratic growth functions Covariates, Study Track (MH vs. SU) © CASAColumbia 2014
  • 26. Clinical Outcomes: Externalizing Symptoms Caregiver Report • Overall declines in aggression, oppositionality, conduct problems • No between-condition differences Adolescent Report • Overall declines in aggression, oppositionality, conduct problems • RFT produced larger effects © CASAColumbia 2014
  • 27. Clinical Outcomes: Internalizing Symptoms Caregiver Report • Overall declines in anxiety, depression, somatic problems • No between- condition differences Adolescent Report • Overall declines in anxiety, depression, somatic problems • RFT produced larger effects © CASAColumbia 2014
  • 28. Clinical Outcomes: Delinquency MH Track • Overall declines in delinquency: proportion any act, total # acts • No between- condition differences SU Track • Overall declines in delinquency: proportion any act, total # acts • RFT larger effects for total # acts © CASAColumbia 2014
  • 29. Clinical Outcomes: Substance Use Full Sample • No overall declines in substance use SU Track • No overall declines in substance use • Significant effects for RFT: proportion any use, # days use © CASAColumbia 2014
  • 30. Brief Conclusions Both RFT and TAU promoted significant gains in multiple problem areas RFT Outperformed TAU for 5 out of 12 outcomes Effect sizes for RFT (small to moderate) comparable to effects reported in meta-analyses of efficacy studies for manualized FTs © CASAColumbia 2014
  • 31. Study Limitations Only 1 RFT Site (However: No measureable cost or organizational advantages for the RFT site) Sample NOT referral as usual Could not analyze site effects Modest attendance rates: (However: Study rates were comparable to routine services) © CASAColumbia 2014
  • 32. Study Implications Routine FT can be delivered with fidelity and effectiveness in usual care What are important differences in fidelity procedures within usual care vs. outside contracts FT is widely endorsed in youth services, but isn’t commonly practiced? With fidelity? Need more research on EBAs used in routine care © CASAColumbia 2014
  • 33. This research was funded by the National Institute on Drug Abuse (R01 DA019607 and R01 DA023945; PI: Aaron Hogue, Ph.D.; Co-I: Sarah Dauber, Ph.D.) © CASAColumbia 2014
  • 34. © CASAColumbia 2014 Related References Hogue, A., Dauber, S., Lichvar, E., Bobek, M., & Henderson, C. E. (in press). Validity of therapist self-report ratings of fidelity to evidence-based practices for adolescent behavior problems: Correspondence between therapists and observers. Administration and Policy in Mental Health and Mental Health Services Research. Hogue, A., Dauber, S., & Henderson, C. E. (2014). Therapist self-report of evidence-based practices in usual care for adolescent behavior problems: Factor and construct validity. Administration and Policy in Mental Health and Mental Health Services Research, 41, 126-139. Hogue, A., & Dauber, S. (2013). Assessing fidelity to evidence-based practices in usual care: The example of family therapy for adolescent behavior problems. Evaluation and Program Planning, 37, 21-30. Hogue, A., & Dauber, S. (2013). Diagnostic profiles among urban adolescents with unmet treatment needs: Comorbidity and perceived need for treatment. Journal of Emotional and Behavioral Disorders, 21, 18-32. Dauber, S., & Hogue, A. (2011). Profiles of systems involvement in a sample of high-risk urban adolescents with unmet treatment needs. Children and Youth Services Review, 33, 2018-2026.